
Covid Vaccines Are Disease-Modifying, Reduce Chances Of Severe Infection, Mortality: ICMR Chief
- byDoctor News Daily Team
- 18 February, 2025
- 0 Comments
- 0 Mins

New Delhi: COVID-19 vaccines reduce the chances of developing severe infection and mortality, ICMR Chief Balram Bhargava said on Tuesday.
Responding to a question about people contracting the coronavirus infection even after taking both doses of COVID vaccine, he said these are "disease-modifying" vaccines and there is an 85 per cent reduction in hospitalization after vaccination which is well established internationally.
Also Read: Case of Guillain-Barré syndrome reported after COVID 19 Vaccination- a report
"These vaccines are disease-modifying. After two doses are administered, the antibodies develop. The COVID-19 vaccines reduce the chances of developing severe infection and death due to the disease," the ICMR Director-General said.
The Indian Council of Medical Research (ICMR) is the country's top health research body.
Currently, two vaccines -- Covaxin by Bharat Biotech and Oxford-AstraZeneca's Covishield manufactured by Serum Institute of India (SII) -- are being used for inoculation in India.
India's drug regulator has also granted permission for the restricted emergency use of the Russian COVID-19 vaccine Sputnik V with certain conditions.
Also Read: Neighbouring states unwilling to supply liquid oxygen to Maharashtra: Health Minister Rajesh Tope
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
Tags:

Recent News
Normal-Tension Glaucoma Closely Associated With Co...
- 10 October, 2022
Air Pollution Tied To Increased Risk Of Premature...
- 24 May, 2023
NEET PG 2024: NBE Opens Pre-Final Edit Window
- 30 May, 2024
NMC Mulls Over Removal Of Upper Age Cap In MBBS En...
- 30 November, 2021

Daily Newsletter
Get all the top stories from Blogs to keep track.
0 Comments
Post a comment
No comments yet. Be the first to comment!